Identification
- Summary
Fraxinus latifolia pollen is an extract from Fraxinus latifolia pollen used in allergy testing.
- Generic Name
- Fraxinus latifolia pollen
- DrugBank Accession Number
- DB10723
- Background
Fraxinus latifolia pollen is the pollen of the Fraxinus latifolia plant. Fraxinus latifolia pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Oregon ash pollen extract
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Oregon Ash Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US 
Oregon Ash Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Oregon Ash Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-04-23 Not applicable US Oregon Ash Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Oregon Ash Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Washington/Oregon Coastal Tree Mixture Fraxinus latifolia pollen (0.0056 g/1mL) + Alnus rhombifolia pollen (0.0056 g/1mL) + Betula occidentalis pollen (0.0056 g/1mL) + Juglans nigra pollen (0.0056 g/1mL) + Juglans regia pollen (0.0056 g/1mL) + Pinus contorta pollen (0.0056 g/1mL) + Populus balsamifera subsp. trichocarpa pollen (0.0056 g/1mL) + Quercus garryana pollen (0.0056 g/1mL) + Salix lucida ssp. lasiandra pollen (0.0056 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1996-07-12 Not applicable US Washington/Oregon Inland Tree Mixture Fraxinus latifolia pollen (0.0056 g/1mL) + Acer negundo pollen (0.0056 g/1mL) + Alnus rhombifolia pollen (0.0056 g/1mL) + Betula occidentalis pollen (0.0056 g/1mL) + Pinus contorta pollen (0.0056 g/1mL) + Pinus ponderosa pollen (0.0056 g/1mL) + Populus balsamifera subsp. trichocarpa pollen (0.0056 g/1mL) + Populus tremuloides pollen (0.0056 g/1mL) + Salix lucida ssp. lasiandra pollen (0.0056 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1996-07-12 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 1FH355G8HF
- CAS number
- Not Available
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53